Breast cancer risk associated with polymorphism in CYP19 in japanese women

International Journal of Cancer

Volumn 89, Issue 4, 2000, Pages 325-328

  Miyoshi, Yasuo ^a   Iwao, Kyoko ^a   Ikeda, Noriko ^a   Egawa, Chiyomi ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ALLELES; AROMATASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CODON; FEMALE; HUMANS; INTRONS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034691559     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000720)89:4<325::AID-IJC2>3.0.CO;2-3     Document Type: Article

References (18)

1. BLANKENSTEIN, M.A., VAN DE VEN, J., MAITIMU-SMEELE, I., DONKER, G.H., DE JONG, P.C., DAROSZEWSKI, J., SZYMCZAK, J., MILEWICZ, A. and THIJSSEN, J.H., Intratumoral levels of estrogens in breast cancer. J. Steroid Biochem. mol. Biol., 69, 293-297 (1999).
2. BONNIER, P., BESSENAY, F., SASCO, A.J., BEEDASSY, B., LEJEUNE, C., ROMAIN, S., CHARPIN, C., PIANA, L. and MARTIN, P.M., Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. Int. J. Cancer, 79, 278-282 (1998).
3. BRODIE, A., LU, Q. and NAKAMURA, J., Aromatase in the normal breast and breast cancer. J. Steroid Biochem. mol. Biol., 61, 281-286 (1997).
4. DUNNING, A.M., HEALEY, C.S., PHAROAH, P.D., TEARE, M.D., PONDER, B.A. and EASTON, D.F., A systematic: review of genetic polymorphisms and breast cancer risk. Cancer epidemiol. Biomarkers Prev., 8, 843-854 (1999).
5. FIRGAIRA, F.A., SESHADRI, R., MCEVOY, C.R., DITE, G.S., GILES, G.G., MCCREDIE, M.R., SOUTHEY, M.C., VENTER, D.J. and HOPPER, J.L., HRASI rare minisatellite alleles and breast cancer in Australian women under age forty years. J. natl. Cancer Inst., 91, 2107-2111 (1999).
6. HAIMAN, C.A., HANKINSON, S.E., SPEIZER, F.E. and HUNTER, D.J., A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Proc. Am. Assoc. Cancer Res., 40, 194 (1999).
7. HSIEH, C.C., TRICHOPOULOS, D., KATSOUYANNI, K. and YUASA, S., Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int. J. Cancer, 46, 796-800 (1990).
8. KELSEY, J.L., Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15, 256-263 (1993).
9. KRISTENSEN, V.N., ANDERSEN, T.I., LINDBLOM, A., ERIKSTEIN, B., MAGNUS, P. and BORRESEN-DALE, A.L., A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics, 8, 43-48 (1998).
10. KRONTIRIS, T.G., DIMARTINO, N.A., COLB, M., PARKINSON, D.R., Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature, 313, 369-374 (1985).
11. KRONTIRIS, T.G., DEVLIN, B., KARP, D.D., ROBERT, N.J. and RISCH, N., An association between the risk of cancer and mutations in the HRASI minisatellite locus. N. Engl. J. Med., 329, 517-523 (1993).
12. KUROSAKI, K., SAITOH, H., OOTA, H., WATANABE, Y., KIUCHI, M. and UEDA, S., Combined polymorphism associated with a 3-bp deletion in the 5′-flanking region of a tetrameric short tandem repeat at the CYP19 locus. Nippon Hoigaku Zasshi, 51, 191-195 (1997).
13. MENDELSON, C.R., MEANS, G.D., MAHENDROO, M.S., CORBIN, C.J., STEINKAMPF, M.P., GRAHAM-LORENCE, S. and SIMPSON, E.R., Use of molecular probes to study regulation of aromatase cytochrome P-450. Biol. Reprod., 42, 1-10 (1990).
14. O'CONNOR, I.F., SHEMBEKAR, M.V. and SHOUSHA, S., Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study. J. Clin. Pathol., 51, 935-938 (1998).
15. SIEGELMANN-DANIELI, N. and BUETOW, K.H., Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk. Brit. J. Cancer, 79, 456-463 (1999).
16. SHIMIZU, H., ROSS, R.K., BERNSTEIN, L., PIKE, M.C. and HENDERSON, B.E., Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Brit. J. Cancer, 62, 451-453 (1990).
17. STEMMERMANN, G.N., The pathology of breast cancer in Japanese women compared with other ethnic groups: a review. Breast Cancer Res. Treat. Suppl. 1, 567-72 (1991).
18. TAKAHASHI, M., KATO, Y., MIYAKAWA, G., KUROSU, A. and KAMIYAMA, S., Allele detection and population study in Japanese using two STR loci (CYP19 and HUMTH01). Int. J. Legal. Med., 108, 321-322 (1996).